{"id":388,"company":{"country":"US","currency":"USD","exchange":"NEW YORK STOCK EXCHANGE, INC.","ipo":"1971-05-27","marketCap":8727.85,"name":"Chemed Corp","phone":"15137626900.0","outstanding":15.06,"symbol":"CHE","website":"https://www.chemed.com/","industry":"Health Care"},"price":577.985,"year":2023,"month":11,"day":3,"weekday":"Friday","title":"Historical Price-to-Book Ratio Trends of Chemed Corp Stock","date":"2023-11-03","url":"/posts/2023/11/03/CHE","content":[{"section":"Introduction to Price-to-Book Ratio","text":"The price-to-book (P/B) ratio is calculated by dividing a company's market price per share by its book value per share. Book value is the value of a company's assets minus its liabilities, which represents the net worth of the company. The P/B ratio reflects the market's valuation of a company in relation to its book value."},{"section":"Historical P/B Ratio Data of Chemed Corp Stock","text":"Date | P/B Ratio\n2021-01-01 | 6.21\n2020-01-01 | 6.38\n2019-01-01 | 6.92\n2018-01-01 | 6.04\n2017-01-01 | 5.62\n2016-01-01 | 5.81\n2015-01-01 | 5.34\n2014-01-01 | 4.96\n2013-01-01 | 5.13"},{"section":"Analysis of P/B Ratio Trends","text":"Based on the historical P/B ratio data of Chemed Corp stock, it can be observed that the P/B ratio has fluctuated over the years but generally remained within a relatively narrow range. The P/B ratio ranged from 4.96 in 2014 to 6.92 in 2019. This indicates that the market has valued Chemed Corp stock at a multiple of its book value, with the ratio fluctuating between approximately 4.96 and 6.92."},{"section":"Relevance for Investors","text":"The historical P/B ratio trends of Chemed Corp stock can be relevant for investors in several ways. Firstly, it provides insights into the market's perception of the company's financial health and growth prospects. A higher P/B ratio may indicate that investors expect higher future earnings and growth from the company. Secondly, comparing the current P/B ratio to historical data can help investors assess whether the stock is undervalued or overvalued. Additionally, investors can use the P/B ratio as a benchmark to compare Chemed Corp's valuation to its industry peers or the overall market."},{"section":"Conclusion","text":"Analyzing the historical P/B ratio trends of Chemed Corp stock provides investors with valuable information regarding the market's valuation of the company. By understanding the P/B ratio trends, investors can make informed decisions about investing in Chemed Corp stock, assess its relative valuation, and evaluate its growth prospects."}],"tags":["CrossOver55","Long","Health Care"],"news":[{"category":"company","date":1698901388,"headline":"Chemed Corp CEO Kevin Mcnamara Sells 5,000 Shares","id":123568134,"image":"https://s.yimg.com/ny/api/res/1.2/MoOYIdL3rzMFkPoEVY6mHQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD01MDY-/https://media.zenfs.com/en/us.finance.gurufocus/8bdea9a03785e1bfc090ffbe29fa07d8","symbol":"CHE","publisher":"Yahoo","summary":"On October 31, 2023, Kevin Mcnamara, the President and CEO of Chemed Corp (NYSE:CHE), sold 5,000 shares of the company.","url":"https://finance.yahoo.com/news/chemed-corp-ceo-kevin-mcnamara-050308912.html"},{"category":"company","date":1698720136,"headline":"RBC Capital Maintains Chemed (CHE) Outperform Recommendation","id":123515084,"image":"","symbol":"CHE","publisher":"Fintel","summary":"","url":"https://fintel.io/news/rbc-capital-maintains-chemed-che-outperform-recommendation-780"},{"category":"company","date":1698651120,"headline":"Chemed price target raised to $604 from $576 at RBC Capital","id":123500491,"image":"","symbol":"CHE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3184962728"},{"category":"company","date":1698643860,"headline":"Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Teladoc (TDOC) and Vertex Pharmaceuticals (VRTX)","id":123500492,"image":"","symbol":"CHE","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3184842724"},{"category":"company","date":1698433440,"headline":"Chemed Corporation (NYSE:CHE) Q3 2023 Earnings Call Transcript","id":123459860,"image":"https://s.yimg.com/ny/api/res/1.2/z9.aTGOMKEqYA67f8ApD7g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/03a301d2dbe12e0ebd5532a1b3a336ba","symbol":"CHE","publisher":"Yahoo","summary":"Chemed Corporation (NYSE:CHE) Q3 2023 Earnings Call Transcript October 26, 2023 Holley Schmidt: Good morning. Our conference call this morning will review the Financial Results for the Third Quarter of 2023 ended September 30, 2023. Before we begin, let me remind you that the safe harbor provisions of the Private Securities Litigation Reform Act of […]","url":"https://finance.yahoo.com/news/chemed-corporation-nyse-che-q3-190400542.html"},{"category":"company","date":1698408480,"headline":"Chemed (CHE) Q3 Earnings and Revenues Surpass, Margins Rise","id":123451968,"image":"https://media.zenfs.com/en/zacks.com/5191fe24e96559c2d90d0319223c2771","symbol":"CHE","publisher":"Yahoo","summary":"Chemed's (CHE) third-quarter 2023 performance reflects strength in the VITAS segment.","url":"https://finance.yahoo.com/news/chemed-che-q3-earnings-revenues-120800707.html"},{"category":"company","date":1698381084,"headline":"Q3 2023 Chemed Corp Earnings Call","id":123451969,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"CHE","publisher":"Yahoo","summary":"Q3 2023 Chemed Corp Earnings Call","url":"https://finance.yahoo.com/news/q3-2023-chemed-corp-earnings-043124979.html"},{"category":"company","date":1698335043,"headline":"Chemed Corporation (CHE) Q3 2023 Earnings Call Transcript","id":123426764,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"CHE","publisher":"SeekingAlpha","summary":"Chemed Corporation (NYSE:NYSE:CHE) Q3 2023 Earnings Conference Call October 26, 2023 10:00 AM ETCompany ParticipantsHolley Schmidt - Assistant...","url":"https://seekingalpha.com/article/4644016-chemed-corporation-che-q3-2023-earnings-call-transcript"},{"category":"company","date":1698317820,"headline":"IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday","id":123419368,"image":"","symbol":"CHE","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179382256"},{"category":"company","date":1698315000,"headline":"CHE Makes Bullish Cross Above Critical Moving Average","id":123419369,"image":"","symbol":"CHE","publisher":"Dividend Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179305533"},{"category":"company","date":1698311100,"headline":"Align Technology, ImmunityBio among healthcare movers","id":123419370,"image":"","symbol":"CHE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179203105"},{"category":"company","date":1698310740,"headline":"Align Technology, ImmunityBio","id":123419371,"image":"","symbol":"CHE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179192088"},{"category":"company","date":1698308640,"headline":"Oppenheimer Sticks to Its Buy Rating for Chemed (CHE)","id":123419372,"image":"","symbol":"CHE","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179139597"},{"category":"company","date":1698295140,"headline":"Chemed’s Consistent Outperformance and Raised Outlooks Bolster Bullish Recommendation","id":123419373,"image":"","symbol":"CHE","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3178881634"},{"category":"company","date":1698283806,"headline":"Chemed (CHE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates","id":123408225,"image":"https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba","symbol":"CHE","publisher":"Yahoo","summary":"The headline numbers for Chemed (CHE) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.","url":"https://finance.yahoo.com/news/chemed-che-q3-earnings-taking-013006768.html"},{"category":"company","date":1698274211,"headline":"Chemed (CHE) Q3 Earnings and Revenues Beat Estimates","id":123406823,"image":"https://media.zenfs.com/en/zacks.com/f889276f4a638f3c7a79c0e3e6b768c1","symbol":"CHE","publisher":"Yahoo","summary":"Chemed (CHE) delivered earnings and revenue surprises of 8.13% and 0.79%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?","url":"https://finance.yahoo.com/news/chemed-che-q3-earnings-revenues-225011370.html"},{"category":"company","date":1698272818,"headline":"Chemed Corp (CHE) Reports Q3 2023 Earnings and Increases Full Year Guidance","id":123408227,"image":"","symbol":"CHE","publisher":"Yahoo","summary":"Key Highlights from Chemed Corp's Q3 2023 Earnings","url":"https://finance.yahoo.com/news/chemed-corp-che-reports-q3-222658305.html"},{"category":"company","date":1698264900,"headline":"Chemed Reports Third-Quarter 2023 Results – Increases Full Year Guidance","id":123408228,"image":"https://media.zenfs.com/en/business-wire.com/f1221670d27e4d5a7ef966dd70e4438a","symbol":"CHE","publisher":"Yahoo","summary":"CINCINNATI, October 25, 2023--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2023, versus the comparable prior-year period.","url":"https://finance.yahoo.com/news/chemed-reports-third-quarter-2023-201500398.html"},{"category":"company","date":1698256080,"headline":"Chemed: Q3 Earnings Snapshot","id":123419374,"image":"","symbol":"CHE","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=a2ya8lmbma"},{"category":"company","date":1698204480,"headline":"Chemed sees 2023 EPS $19.82-$20.02, consensus $19.98","id":123397339,"image":"","symbol":"CHE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3177743927"},{"category":"company","date":1698204420,"headline":"Chemed reports Q3 adjusted EPS $5.32, consensus $4.90","id":123397340,"image":"","symbol":"CHE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3177742337"},{"category":"company","date":1698204360,"headline":"Chemed Non-GAAP EPS of $5.32 beats by $0.42, revenue of $565M beats by $6.58M","id":123397341,"image":"","symbol":"CHE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3177739756"},{"category":"company","date":1698145560,"headline":"Preview: Chemed's Earnings","id":123368951,"image":"","symbol":"CHE","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3175378308"},{"category":"company","date":1698122220,"headline":"Chemed Q3 2023 Earnings Preview","id":123397343,"image":"","symbol":"CHE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3175905755"},{"category":"company","date":1698122220,"headline":"Notable earnings after Wednesday's close","id":123372884,"image":"","symbol":"CHE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3175905736"},{"category":"company","date":1697816411,"headline":"OPCH or CHE: Which Is the Better Value Stock Right Now?","id":123306902,"image":"https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee","symbol":"CHE","publisher":"Yahoo","summary":"OPCH vs. CHE: Which Stock Is the Better Value Option?","url":"https://finance.yahoo.com/news/opch-che-better-value-stock-154011247.html"}]}